Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment (Q46641346)
scientific article published on August 1, 1998
Language:
(P31) (Q13442814)
(P304) 2659-2671
(P407) (Q1860)
(P433) 8
(P478) 16
(P577) Saturday, August 1, 1998
Saturday, August 1, 1998
(P921) (Q61643320)
(Q79460)
(Q974135)
(Q412415)
(Q12859063)
(Q422248)
(P953) http://intl.jco.org/cgi/content/abstract/16/8/2659
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.1998.16.8.2659
(P1433) (Q400292)
(P1476) "Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment" (language: en)
(P2093) M. D. Pegram
A. Lipton
D. F. Hayes
B. L. Weber
J. M. Baselga
D. Tripathy
D. Baly
S. A. Baughman
T. Twaddell
J. A. Glaspy
D. J. Slamon
other details
description scientific article published on August 1, 1998

External Links